bioMérieux is a worldwide group specializing in the field of in vitro diagnostics for clinical and industrial applications.

In 2003, bioMérieux’s consolidated revenues reached 915 million euros. bioMérieux is present in more than 130 countries through 33 subsidiaries and a large network of distributors. In 2003, we earned 28% of our consolidated revenues in North America and 56% in Europe, including 19% in France.